IP Library Granted Patent US 11,819,671
Granted Patent B2
US 11,819,671 · App. 17/518,139 · Granted Nov 21, 2023

Medicament delivery device

Inventor: Mattias Daniel (Stockholm, SE)
Assignee: SHL MEDICAL AG
A61M5/3157A61M5/20A61M5/2033A61M5/24A61M5/3158A61M5/31501A61M5/31511A61M5/31515A61M5/31585A61M5/3243H05K999/99A61M5/3202A61M2005/208A61M2005/2013A61M2005/2485A61M2205/581A61M2205/582A61M2205/583A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,671
App. No.
17/518,139
Granted
Nov 21, 2023
Kind
B2
Abstract

A medicament delivery device is presented having a drive configured to act on a medicament container for expelling a medicament; a holder configured to hold said drive in a pre-tensioned state; an activator configured to interact with said holder for releasing said drive from the pre-tensioned state; wherein the device further includes a feedback mechanism configured to interact both with said holder and with said drive for generating an audible and/or tactile and/or visual signal indicating that the medicament has been completely expelled.

Claims (34)

1. A medicament delivery device comprising:

a housing having a proximal end;

a pre-filled syringe positioned within the housing and comprising a needle, a dose of medicament and a sliding stopper, wherein the syringe is axially fixed relative to the housing during a delivery of the dose of medicament through the needle such that a proximal end of the needle remains axially fixed relative to the housing before and after the delivery of the dose of medicament;

a tubular activation member comprising two distally projecting arms and a proximal end portion terminating in a radial flange comprising an inside ledge, where the tubular activation member is slidably positioned within the housing to move from a first position to a second position and then to a final locked position;

a spring located in the proximal end portion of the tubular activation member such that a terminal proximal end of the spring abuts the inside ledge, where the spring is in a compressed state when the tubular activation member is in the second position;

a plunger rod operatively connected to the stopper, where the plunger rod can only move proximally relative to the tubular activation member when the tubular activation member is in the second position;

wherein each of the distally projecting arms comprises a distal portion that forms a lock when the tubular activation member is in the final locked position such that the tubular activation member is prevented from moving distally relative to the housing to expose the axially fixed needle, and

wherein the radial flange is positioned outside of the proximal end of the housing when the tubular activation member is in the first position, the second position, and the final locked position.

2. The delivery device of claim 1 , wherein the proximal end portion of the tubular activation member extends longitudinally from the radial flange and has an outer diameter.

3. The delivery device of claim 2 , where the radial flange comprises a terminal end face having a diameter greater than the outer diameter of the proximal end portion.

4. The delivery device of claim 1 , wherein the radial flange has a terminal end face configured for direct contact with an injection site.

5. The delivery device of claim 1 , wherein the spring is positioned inside the tubular activation member to bias the proximal end portion of the tubular activation member proximally when the tubular activation member is in the first position.

6. The delivery device of claim 1 , wherein the housing has an outer surface and the proximal end portion of the tubular activation member extends distally and longitudinally from the radial flange, where the tubular activation member slides relative to the outer surface when the tubular activation member moves from the first position to the second position and then to the final locked position.

7. The delivery device of claim 1 , wherein the proximal end of the needle protrudes beyond a terminal end face of the radial flange when the tubular activation member is in the second position.

8. The delivery device of claim 1 , wherein the tubular activation member further comprises a protrusion located at a distal end that forms a part of the lock when the tubular activation member is the final locked position.

9. The delivery device of claim 1 , wherein the tubular activation member is rotationally fixed relative to the housing.

10. The delivery device of claim 1 , wherein the tubular activation member further comprises a distal end comprising a protrusion.

11. A medicament delivery device comprising:

a housing having a proximal end;

a pre-filled syringe positioned within the housing and comprising a needle having a proximal end, where the syringe is axially fixed relative to the housing during a delivery of a medicament through the needle such that the proximal end of the needle remains axially fixed relative to the housing before and after the delivery of the medicament;

a tubular activation member comprising two distally projecting arms and a proximal end portion terminating in a radial flange comprising an inside ledge, where the tubular activation member is slidably positioned within the housing to move from a first position to a second position and then to a final locked position, where the radial flange is positioned proximal of the proximal end of the needle when the tubular activation member is in the first position and the final locked position;

a spring located in the proximal end portion of the tubular activation member such that a terminal proximal end of the spring abuts the inside ledge, where the spring is in a compressed state when the tubular activation member is in the second position such that the proximal end portion is biased to axially move in a proximal direction as the tubular activation member slidably moves from the second position to the final locked position;

wherein each of the distally projecting arms comprises a distal portion that forms a lock when the tubular activation member is in the final locked position such that the tubular activation member is prevented from moving distally relative to the housing to expose the axially fixed needle, and

wherein the radial flange is positioned outside of the proximal end of the housing when the tubular activation member is in the first position, the second position, and the final locked position.

12. A medicament delivery device comprising:

a housing having a proximal end;

a pre-filled syringe positioned within the housing and comprising a needle, a dose of medicament and a sliding stopper, where the syringe is axially fixed relative to the housing during a delivery of the dose of medicament through the needle such that a proximal end of the needle remains axially fixed relative to the housing before and after the delivery of the dose of medicament;

a tubular activation member comprising two distally projecting arms and a proximal end portion having an outer diameter and terminating in a radial flange comprising an inside ledge, where the tubular activation member is slidably positioned within the housing to move from a first position to a second position and then to a final locked position;

a spring located in the proximal end portion of the tubular activation member such that a terminal proximal end of the spring abuts the inside ledge, where the spring is in a compressed state when the tubular activation member is in the second position such that the proximal end portion is biased to axially move in a proximal direction as the tubular activation member slidably moves from the second position to the final locked position;

wherein each of the distally projecting arms comprises a distal portion that forms a lock when the tubular activation member is in the final locked position such that the tubular activation member is prevented from moving distally relative to the housing to expose the axially fixed needle,

wherein the radial flange is positioned outside of the proximal end of the housing when the tubular activation member is in the first position, the second position, and the final locked position,

wherein the spring is positioned inside the tubular activation member to bias the proximal end portion of the tubular activation member proximally when the tubular activation member is in the first position, and

where the radial flange comprises a terminal end face having a diameter greater than the outer diameter of the proximal end portion.

13. The delivery device of claim 12 , where the radial flange is positioned proximal of the proximal end of the needle when the tubular activation member is in the first position and the final locked position.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2021
From: SHL GROUP AB
To: SHL MEDICAL AG
Reel/Frame 058010/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2021
From: DANIEL, MATTIAS
To: SHL GROUP AB
Reel/Frame 058010/0264 →
Priority Claims (1)
SE 1050307-6 · Mar 31, 2010 · national
Continuity (8)
Continuation 17323382 · May 18, 2021
Continuation 17114241 · Dec 7, 2020
Continuation 15994381 · May 31, 2018
Continuation 15480820 · Apr 6, 2017
Continuation 13650708 · Oct 12, 2012
Continuation 13636241
Provisional Application 61319453 · Mar 31, 2010
Related Publication 20220054759A1 · Feb 24, 2022
Cited By (1)
US 12,226,614